Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel

Details for Australian Patent Application No. 2001270809 (hide)

International Classifications

Event Publications

13 April 2006 Application Accepted

Published as AU-B-2001270809

10 August 2006 Standard Patent Sealed

19 October 2006 Section 223 Application Received

University of Bristol An application to extend the time from 06 Nov 2005 to 06 Sep 2006 in which to file search results has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2003

21 December 2006 Section 223 Application Allowed

University of Bristol The time in which to file search results has been extended to 06 Sep 2006. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2002

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.